[Federal Register Volume 77, Number 88 (Monday, May 7, 2012)]
[Notices]
[Page 26771]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-10967]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Scientific Management Review Board.
    The NIH Reform Act of 2006 (Pub. L. 109-482) provides 
organizational authorities to HHS and NIH officials to: (1) Establish 
or abolish national research institutes; (2) reorganize the offices 
within the Office of the Director, NIH including adding, removing, or 
transferring the functions of such offices or establishing or 
terminating such offices; and (3) reorganize, divisions, centers, or 
other administrative units within an NIH national research institute or 
national center including adding, removing, or transferring the 
functions of such units, or establishing or terminating such units. The 
purpose of the Scientific Management Review Board (also referred to as 
SMRB or Board) is to advise appropriate HHS and NIH officials on the 
use of these organizational authorities and identify the reasons 
underlying the recommendations. The meeting will be open to the public 
through teleconference at the number listed below.

    Name of Committee: Scientific Management Review Board.
    Date: May 29, 2012.
    Time: 12:15 p.m. to 2:15 p.m.
    Agenda: Presentation and discussion will focus on the most 
recent charge to the SMRB, which entails recommending strategies for 
how NIH can optimize its utilization on the Small Business 
Innovation Research and Small Business Technology Transfer programs 
in keeping with the NIH mission. The Board will also discuss next 
steps regarding future SMRB activities. Further information for this 
meeting, including the agenda will be available at http://smrb.od.nih.gov. Time will be allotted on the agenda for public 
comment. To sign up for public comment, please submit your name and 
affiliation to the contact person listed below by May 25, 2012. Sign 
up will be restricted to one sign up per email. In the event that 
time does not allow for all those interested to present oral 
comments, anyone may file written comments using the contact 
person's address below.
    The toll-free number to participate in the teleconference is 1-
800-779-1545. Indicate to the conference operator that your 
Participant pass code is ``NIH.''
    Place: National Institutes of Health, Office of the Director, 
NIH, Office of Science Policy, 6705 Rockledge Drive, Suite 750, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Lyric Jorgenson, Ph.D., Office of Science 
Policy, Office of the Director, NIH, National Institutes of Health, 
6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, 
[email protected], (301) 496-6837.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    The draft meeting agenda, meeting materials, dial-in 
information, and other information about the SMRB, will be available 
at http://smrb.od.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: May 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-10967 Filed 5-4-12; 8:45 am]
BILLING CODE 4140-01-P